PCNA and central nervous system cancer: In contrast, in the CAPE-treated group, the histochemical and immunohistochemical analysis revealed that CAPE treatment significantly reduced the number of PCNA-positive cells, consistent with the results of Mir et al. [51], who found that CAPE led to the inhibition of PCNA expression in glioma cell proliferation and could prove to be an effective adjunct to therapies.